Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study (original) (raw)

Serum Haloperidol Concentration and Clinical Response in Schizophrenia

Schizophrenia Bulletin, 1988

Risk of Mortality Among Patients Treated With Antipsychotic Medications

Journal of Clinical Psychopharmacology, 2016

Ultra-Rapid, Unexpected, and Full Remission of Manic Episode after Treatment with Haloperidol High Doses – 2 Case Reports

Victoria Burtea

Journal of Clinical Case Reports, 2016

View PDFchevron_right

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

Ronald Marcus

The International Journal of Neuropsychopharmacology, 2003

View PDFchevron_right

Tranquilising agitated mentally ill patients: intramuscular haloperidol plus promethazine reduces need for additional medication or medical attention compared to olanzapine

Prathap Tharyan

Evidence-based Mental Health, 2008

View PDFchevron_right

P.2.020 Comparison of efficacy and tolerability of quetiapine and haloperidol in acute exacerbation of chronic or subchronic schizophrenia

M. Bilici

European Neuropsychopharmacology, 2003

View PDFchevron_right

Haloperidol blood levels and clinical outcome: a meta-analysis of studies relevant to testing the therapeutic window hypothesis

Nelson Oliveira

Journal of Clinical Pharmacy and Therapeutics, 1996

View PDFchevron_right

Novel Antipsychotics and Severe Hyperlipidemia

Serge Beaulieu

Journal of Clinical Psychopharmacology, 2001

View PDFchevron_right

Antipsychotic management in primary care: a longitudinal population-based study

Sally Sheard

medRxiv (Cold Spring Harbor Laboratory), 2024

View PDFchevron_right

Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia

Robert Rosenheck

New England Journal of Medicine, 2011

View PDFchevron_right

Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients

Eva Peñas Lledó

European Journal of Clinical Pharmacology, 2007

View PDFchevron_right

Haloperidol Versus Second-Generation Antipsychotics in the Long-Term Treatment of Schizophrenia

Massimo Carlo Mauri

Journal of Clinical Psychopharmacology, 2011

View PDFchevron_right

Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode

Franca Centorrino

Schizophrenia Research, 2005

View PDFchevron_right

Novel Antipsychotic Drugs Approved in 2015: Brexpiprazole, Cariprazine, Aripiprazole Lauroxil

Canan Kuş

Medicinal chemistry, 2016

View PDFchevron_right

Evaluation of patients on sertindole treatment after failure of other antipsychotics: A retrospective analysis

Karina Hansen

BMC Psychiatry, 2008

View PDFchevron_right

Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults

Lissette Saavedra

2012

View PDFchevron_right

Retrospective database analysis on the effectiveness of typical and atypical antipsychotic drugs in an outpatient clinic setting

SELÇUK KIRLI

Human Psychopharmacology: Clinical and Experimental, 2007

View PDFchevron_right

Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety

Nicholas Keks

Clinical …, 1998

View PDFchevron_right

Metabolic side-effects of novel antipsychotic drugs

Darko Marčinko

Biochemia Medica, 2007

View PDFchevron_right

Antipsychotic prescription trends according to ethnicity

Aqeel Hashmi

Psychiatric Bulletin, 2009

View PDFchevron_right

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity

Madelon Price

Biological Psychiatry, 1993

View PDFchevron_right

Clinical and biological outcomes of prolonged treatment with haloperidol in schizophrenia

FELICIA MILITARU

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2016

View PDFchevron_right

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends

Jonathan Favre

Current Pharmaceutical Design, 2015

View PDFchevron_right

Incidence of Newly Diagnosed Diabetes Attributable to Atypical Antipsychotic Medications

Robert Rosenheck

American Journal of Psychiatry, 2004

View PDFchevron_right

Haloperidol: A Novel Use in Ketamine Induced Postoperative Fulminant Psychosis

Kashif Jamal

International Journal of Science and Research (IJSR), 2016

View PDFchevron_right

Risperidone vs. Haloperidol in the treatment of schizophrenia: A meta-analysis comparing their efficacy and safety

Irismar Reis de Oliveira

European Neuropsychopharmacology, 1996

View PDFchevron_right

Management of Adverse Effects of Second-generation Antipsychotics in Youth

Marianna Giannitelli

Current Treatment Options in Psychiatry, 2014

View PDFchevron_right

Comparative mortality risks of antipsychotic medications in community-dwelling older adults

S. Crystal

The British Journal of Psychiatry, 2013

View PDFchevron_right

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia

Daniel Van Kammen

Journal of Psychiatric Research, 1998

View PDFchevron_right

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

Robert Rosenheck

Schizophrenia Research, 2008

View PDFchevron_right

Neurological Adverse Effects of Antipsychotics in Children and Adolescents

cecilia tapia

Journal of Clinical Psychopharmacology, 2015

View PDFchevron_right

Association between antipsychotics and adverse outcomes in dementia

Ayesha Bangash

Progress in Neurology and Psychiatry, 2017

View PDFchevron_right

An Evaluation of Efficacy and Safety of Antipsychotic Medications in Patients Suffering from Psychiatric Illness

Anuradha Gandhi

2013

View PDFchevron_right

Adverse Drug Reactions Affiliated with Atypical Antipsychotics in Patients with Schizophrenia

shweta oommen

Journal of Young Pharmacists, 2019

View PDFchevron_right

Pharmacology of atypicality of antipsychotic drugs: status and perspectives

Adrian Newman-Tancredi

Archives of Psychiatry and …, 2010

View PDFchevron_right

Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study (original) (raw)

Related papers